Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,942,561 papers from all fields of science
Search
Sign In
Create Free Account
imiquimod 50 MG/ML Topical Cream
Known as:
imiquimod 50 mg in 1000 mg TOPICAL CREAM [Imiquimod]
, IMIQUIMOD 12.5 mg in 0.25 g TOPICAL CREAM
, IMIQUIMOD 5% TOP CREAM PKT 0.25GM
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
Benzyl Alcohol
Condylomata Acuminata
Drug Allergy
Glycerin
Expand
Narrower (1)
imiquimod 50 MG/ML Topical Cream [Aldara]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Electrospun Poly(ε-caprolactone) Nanofibrous Mesh for Imiquimod Delivery in Melanoma Therapy
Wei-Chih Lin
,
I. Yeh
,
Eri Niyama
,
Wan-Rou Huang
,
M. Ebara
,
Chieh-Shan Wu
Polymers
2018
Corpus ID: 91185022
Drug delivery systems (DDS) are commonly employed to administer drug-loaded composites to their therapeutic targets both in vitro…
Expand
2017
2017
Isogarcinol Extracted from Garcinia mangostana L. Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in Mice.
Shanzao Chen
,
K. Han
,
+4 authors
Q. Wei
Journal of Agricultural and Food Chemistry
2017
Corpus ID: 206604520
Isogarcinol (YDIS), a natural compound extracted from Garcinia mangostana L., has a significant immunosuppressive effect on…
Expand
2017
2017
Non-thermal atmospheric plasma ameliorates imiquimod-induced psoriasis-like skin inflammation in mice through inhibition of immune responses and up-regulation of PD-L1 expression
Y. Lee
,
Myung‐Hoon Lee
,
Hang-Jun Kim
,
Ho-Ryun Won
,
Chul-Ho Kim
Scientific Reports
2017
Corpus ID: 205626246
Plasma medicine is an emerging novel therapeutic field. It has been reported that plasma can kill bacteria, promote wound healing…
Expand
Highly Cited
2012
Highly Cited
2012
Blockade of Phosphatidylinositol 3-Kinase (PI3K)δ or PI3Kγ Reduces IL-17 and Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis
Anne Roller
,
A. Perino
,
+4 authors
H. Ji
Journal of Immunology
2012
Corpus ID: 26073114
Psoriasis is a chronic inflammatory skin disease triggered by interplay between immune mediators from both innate and adaptive…
Expand
2011
2011
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.
Chun-mei Cheng
,
P. Jain
,
I. Bettahi
,
S. Pal
,
D. Tifrea
,
L. M. de la Maza
Vaccine
2011
Corpus ID: 37162516
2009
2009
Involvement of interleukin-1 receptor-associated kinase (IRAK)-M in toll-like receptor (TLR) 7-mediated tolerance in RAW 264.7 macrophage-like cells.
F. Hassan
,
S. Islam
,
+6 authors
T. Yokochi
Cellular Immunology
2009
Corpus ID: 21139746
2009
2009
Imiquimod tópico al 5% como alternativa terapéutica en la enfermedad de Paget extramamaria primaria
A. Martorell-Calatayud
,
O. Sanmartín-Jiménez
,
B. Escutia-Muñoz
,
C. Guillén-Barona
2009
Corpus ID: 70763963
Highly Cited
2008
Highly Cited
2008
Presymptomatic differences in Toll-like receptor function in infants who have allergy.
S. Prescott
,
P. Noakes
,
+6 authors
M. Tulic
Journal of Allergy and Clinical Immunology
2008
Corpus ID: 23834877
2008
2008
FAK-mediated activation of ERK for eosinophil migration: a novel mechanism for infection-induced allergic inflammation.
P. F. Cheung
,
C. Wong
,
W. Ip
,
C. Lam
International Immunology
2008
Corpus ID: 205141724
Bacterial and viral infections often induce the exacerbation of allergic diseases. In this study, we investigated the activation…
Expand
Highly Cited
2007
Highly Cited
2007
Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils.
C. Wong
,
P. F. Cheung
,
W. Ip
,
C. Lam
American Journal of Respiratory Cell and…
2007
Corpus ID: 23940416
Activation of eosinophils by microbe-derived molecules via Toll-like receptors (TLR) potentially provides the link between…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE